オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - remifentanil hydrochloride, quantity: 5.485 mg (equivalent: remifentanil, qty 5 mg) - injection, powder for - excipient ingredients: glycine - ultiva for injection is indicated- as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults; as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical but not cardiac procedures in children aged 1 to 12 years; for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery-when endotracheal intubation and controlled ventillation are anticipated. for provision of analgesia and sedation in mechanically ventilated intensive care patients.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - remifentanil hydrochloride, quantity: 2.194 mg (equivalent: remifentanil, qty 2 mg) - injection, powder for - excipient ingredients: glycine - ultiva for injection is indicated- as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults; as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical but not cardiac procedures in children aged 1 to 12 years; for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery-when endotracheal intubation and controlled ventillation are anticipated. for provision of analgesia and sedation in mechanically ventilated intensive care patients.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - remifentanil hydrochloride, quantity: 1.097 mg (equivalent: remifentanil, qty 1 mg) - injection, powder for - excipient ingredients: glycine - ultiva for injection is indicated- as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults; as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical but not cardiac procedures in children aged 1 to 12 years; for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery-when endotracheal intubation and controlled ventillation are anticipated. for provision of analgesia and sedation in mechanically ventilated intensive care patients.

イスラエル - 英語 - Ministry of Health

padagis israel agencies ltd, israel - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 5 mg/vial - remifentanil - remifentanil - ultiva is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision . ultiva is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

cultivated) (avena sativa) pollen 50,000bu/ml solution for skin prick test (allergopharma - oat (cultivated) (avena sativa) pollen allergen extract - solution for skin-prick test

イスラエル - 英語 - Ministry of Health

perrigo israel agencies ltd - remifentanil as hydrochloride - powder for reconstitution for solution for injection - remifentanil as hydrochloride 1 mg/vial - remifentanil - remifentanil - ultiva is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision . ultiva is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

イスラエル - 英語 - Ministry of Health

perrigo israel agencies ltd - remifentanil as hydrochloride - powder for reconstitution for solution for injection - remifentanil as hydrochloride 2 mg/vial - remifentanil - remifentanil - ultiva is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision . ultiva is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

guna spa - cultivated mushroom (unii: 54c8e6w6jy) (cultivated mushroom - unii:54c8e6w6jy), anti-interleukin-1.alpha. immunoglobulin g rabbit (unii: ml4qrz1hcl) (anti-interleukin-1.alpha. immunoglobulin g rabbit - unii:ml4qrz1hcl), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i), berberis vulgaris root bark (unii: 1th8q20j0u) (berberis vulgaris root bark - unii:1th8q20j0u), metenkefalin (unii: 9jez9od3as) (metenkefalin - unii:9jez9od3as), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - - cultivated mushroom 4 [hp_x] in 30 ml - agaricus campestris         4x    antispastic anti interleukin 1 alpha      4c    anti-inflammatory atropinum sulfuricum         6x    pain relief berberis vulgaris         3x    detoxification beta-endorphin             4c    pain relief chelidonium majus         4x    detoxification cobaltum metallicum         4x    antispastic colocynthis             4x    back sore gelsemium              6x     analgesic interleukin 10             4c    anti-inflammatory magnesium metallicum         4x    antispastic melatonin             4c    antispastic sympathetic nerve        200x    pain relief vagal nerve            6x    pain relief temporary relief of: - muscle spasms - colic gas pain take 15 minutes before meals

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

mylan institutional llc - remifentanil hydrochloride (unii: 5v444h5wic) (remifentanil - unii:p10582jyyk) - remifentanil 1 mg in 1 ml - ultiva is indicated for intravenous (iv) administration: ultiva is contraindicated: prolonged use of opioid analgesics during pregnancy may cause neonatal opioid withdrawal syndrome. available data with remifentanil hydrochloride in pregnant women are insufficient to inform a drug-associated risk for major birth defects and miscarriage. in animal reproduction studies, reduced fetal rat body weight and pup weights were reported at 2.2 times a human intravenous infusion of an induction dose of 1 mcg/kg with a maintenance dose of 2 mcg/kg/min for a surgical procedure lasting 3 hours. there were no malformations noted when remifentanil was administered via bolus injection to pregnant rats or rabbits during organogenesis at doses approximately 5 times and approximately equal, respectively, to a human intravenous infusion of an induction dose of 1 mcg/kg with a maintenance dose of 2 mcg/kg/min for a surgical procedure lasting 3 hours [see data ]. the estimated background risk of major birth defects and miscarriage

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

mylan institutional llc - remifentanil hydrochloride (unii: 5v444h5wic) (remifentanil - unii:p10582jyyk) - ultiva is indicated for intravenous (iv) administration: ultiva is contraindicated: prolonged use of opioid analgesics during pregnancy may cause neonatal opioid withdrawal syndrome. available data with remifentanil hydrochloride in pregnant women are insufficient to inform a drug-associated risk for major birth defects and miscarriage. in animal reproduction studies, reduced fetal rat body weight and pup weights were reported at 2.2 times a human intravenous infusion of an induction dose of 1 mcg/kg with a maintenance dose of 2 mcg/kg/min for a surgical procedure lasting 3 hours. there were no malformations noted when remifentanil was administered via bolus injection to pregnant rats or rabbits during organogenesis at doses approximately 5 times and approximately equal, respectively, to a human intravenous infusion of an induction dose of 1 mcg/kg with a maintenance dose of 2 mcg/kg/min for a surgical procedure lasting 3 hours [see data ]. the estimated background risk of major birth defects and miscarriage